Kaibori Masaki, Ishizaki Morihiko, Iida Hiroya, Matsui Kosuke, Sakaguchi Tatsuma, Inoue Kentaro, Mizuta Toshihiko, Ide Yasushi, Iwasaka Junji, Kimura Yutaka, Hayashi Fumikazu, Habu Daiki, Kon Masanori
Department of Surgery, Hirakata Hospital, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, Osaka, 573-1191, Japan,
J Gastrointest Surg. 2015 Jul;19(7):1315-23. doi: 10.1007/s11605-015-2838-8. Epub 2015 May 12.
It has recently been reported that myosteatosis, the infiltration of fat in skeletal muscle, is associated with insulin resistance and type 2 diabetes mellitus. The present study investigated the effect of skeletal muscle fat accumulation on short- and long-term outcomes following partial hepatectomy for hepatocellular carcinoma (HCC) and aimed to identify prognostic factors.
The records of 141 HCC patients who underwent hepatectomy were retrospectively reviewed. Clinicopathological and outcome data from 71 patients with high intramuscular adipose tissue content (IMAC) were compared with those from 70 patients with low IMAC.
The 5-year overall survival rate was 46% among patients with high IMAC and 75% among those with low IMAC. The 5-year disease-free survival rates in these groups were 18 and 38%, respectively. Multivariate analysis revealed that high IMAC was predictive of an unfavorable prognosis. High IMAC was significantly correlated with liver dysfunction, higher intraoperative blood loss, the need for blood transfusion, and comorbid diabetes mellitus.
Greater fat accumulation in skeletal muscle was predictive of worse overall survival after partial hepatectomy in patients with HCC, even with adjustment for other known predictors. The identification of patients with greater skeletal muscle fat accumulation before hepatectomy could permit early preventive strategies to maintain muscle quality and thus improve prognosis and patient selection for hepatectomy.
最近有报道称,肌脂肪变性,即脂肪在骨骼肌中的浸润,与胰岛素抵抗和2型糖尿病有关。本研究调查了骨骼肌脂肪堆积对肝细胞癌(HCC)部分肝切除术后短期和长期预后的影响,并旨在确定预后因素。
回顾性分析141例行肝切除术的HCC患者的记录。将71例肌肉内脂肪组织含量(IMAC)高的患者与70例IMAC低的患者的临床病理和预后数据进行比较。
IMAC高的患者5年总生存率为46%,IMAC低的患者为75%。这些组的5年无病生存率分别为18%和38%。多因素分析显示,高IMAC预示预后不良。高IMAC与肝功能障碍、术中失血量增加、输血需求和合并糖尿病显著相关。
即使对其他已知预测因素进行校正,骨骼肌中脂肪堆积较多也预示着HCC患者部分肝切除术后总体生存率较差。在肝切除术前识别骨骼肌脂肪堆积较多的患者,可以采取早期预防策略来维持肌肉质量,从而改善预后并优化肝切除患者的选择。